| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.11B | $5.55B | $5.48B |
| YoY Revenue Growth % | +10.0% | +1.4% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $658.5M | $471.9M | $524.5M |
| Operating Margin % | 10.8% | 8.5% | 9.6% |
| Net Income (GAAP) | $1.31B | $588.3M | $950.3M |
| EBITDA (Normalized) | $878.5M | $671.8M | $721.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.41B | $2.26B | $1.63B |
| Capital Expenditures (CapEx) | $275.1M | $250.0M | $246.5M |
| Free Cash Flow (FCF) | $2.14B | $2.01B | $1.39B |
| FCF Margin % | 35.0% | 36.2% | 25.3% |
| Return on Invested Capital (ROIC %) | 1.7% | 1.4% | 1.8% |
| Cash & Short-Term Equivalents | $3.45B | $3.87B | — |
| Total Debt (Short + Long Term) | $11.05B | $9.95B | $8.71B |
| Total Stockholders' Equity | $22.93B | $21.34B | $17.87B |